Jingliang Wang
Jinan, 250002, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Corrigendum to "Serum iron element: A novel biomarker for predicting PD-1 immunotherapy efficacy" [Int. Immunopharmacol. 131 (2024) 111823].
Journal: International immunopharmacology
Published: November 28, 2024
Serum zinc as a biomarker to predict the efficacy of immune checkpoint inhibitors in cancers.
Journal: PloS one
Published: November 09, 2024
Serum iron element: A novel biomarker for predicting PD-1 immunotherapy efficacy.
Journal: International immunopharmacology
Published: January 03, 2024
HER2-positive breast cancer progresses rapidly after pyrotinib resistance: acquired RET gene fusion and TP53 gene mutation are potential reasons.
Journal: Anti-cancer drugs
Published: January 23, 2023
Potential mechanism of pyrotinib-induced diarrhea was explored by gut microbiome and ileum metabolomics.
Journal: Anti-cancer drugs
Published: November 15, 2022
Effects of Shenling Baizhu powder on pyrotinib-induced diarrhea: analysis of gut microbiota, metabonomics, and network pharmacology.
Journal: Chinese medicine
Published: September 30, 2022
The Real-world Therapeutic Analysis of First-line Immunotherapy in Chinese Patients with Drive Gene Positive for Advanced Non-Small Cell Lung Cancer.
Journal: Journal of Cancer
Published: July 17, 2022
Clinical characteristics and prognostic factors of patients with non-small cell lung cancer having HER2 alterations.
Journal: Journal of cancer research and clinical oncology
Published: April 06, 2022
Association analysis between MDR1 genetic variant and breast cancer risk factors in Chinese Han population.
Journal: Medical oncology (Northwood, London, England)
Published: June 17, 2013
Increased risk of high-grade hemorrhage in cancer patients treated with gemcitabine: a meta-analysis of 20 randomized controlled trials.
Journal: PloS one
Published: May 02, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026